Literature DB >> 22311899

The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension.

Vesna D Garovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22311899      PMCID： PMC3285503          DOI： 10.1161/HYPERTENSIONAHA.111.184192

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  11 in total

1.  Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy.

Authors:  Uma Perni; Cristina Sison; Vijay Sharma; Geri Helseth; Amret Hawfield; Manikkam Suthanthiran; Phyllis August
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

2.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

Review 3.  Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review.

Authors:  Mariana Widmer; José Villar; Ariela Benigni; Agustin Conde-Agudelo; S Ananth Karumanchi; Marshall Lindheimer
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

4.  Preeclampsia: an endothelial cell disorder.

Authors:  J M Roberts; R N Taylor; T J Musci; G M Rodgers; C A Hubel; M K McLaughlin
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

5.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 7.  Prediction and prevention of recurrent preeclampsia.

Authors:  John R Barton; Baha M Sibai
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

8.  Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?

Authors:  Baha M Sibai; Matthew A Koch; Salvio Freire; Joao Luiz Pinto e Silva; Marilza Vieira Cunha Rudge; Sérgio Martins-Costa; Janet Bartz; Cleide de Barros Santos; Jose Guilherme Cecatti; Roberto Costa; José Geraldo Ramos; Joseph A Spinnato
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

9.  Delayed postpartum preeclampsia: an experience of 151 cases.

Authors:  Laura A Matthys; Kristin H Coppage; Donna S Lambers; John R Barton; Baha M Sibai
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

10.  A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy.

Authors:  Phyllis August; Geraldine Helseth; E Francis Cook; Cristina Sison
Journal:  Am J Obstet Gynecol       Date:  2004-11       Impact factor: 8.661
View more
  8 in total

Review 1.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

2.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

3.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

4.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

5.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

6.  Recent advances in the understanding of the pathophysiology of preeclampsia.

Authors:  Junie P Warrington; Eric M George; Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Hypertension       Date:  2013-07-29       Impact factor: 10.190

Review 7.  A comprehensive review of hypertension in pregnancy.

Authors:  Reem Mustafa; Sana Ahmed; Anu Gupta; Rocco C Venuto
Journal:  J Pregnancy       Date:  2012-05-23

8.  Prenatal serum sFlt-1/PlGF ratio predicts the adverse neonatal outcomes among small-for-gestational-age fetuses in normotensive pregnant women: A prospective cohort study.

Authors:  So Hyun Shim; Haeng Jun Jeon; Hye Jin Ryu; So Hyun Kim; Seung Gi Min; Min Kyu Kang; Hee Jin Park; Dong Hyun Cha
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.